IL84223A0 - Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement - Google Patents
Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancementInfo
- Publication number
- IL84223A0 IL84223A0 IL84223A IL8422387A IL84223A0 IL 84223 A0 IL84223 A0 IL 84223A0 IL 84223 A IL84223 A IL 84223A IL 8422387 A IL8422387 A IL 8422387A IL 84223 A0 IL84223 A0 IL 84223A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor agonists
- adrenergic receptor
- containing alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/928,442 US4847300A (en) | 1986-11-07 | 1986-11-07 | Use of alpha-2I selective adrenergic receptor agonists in memory enhancement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84223A0 true IL84223A0 (en) | 1988-03-31 |
Family
ID=25456234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84223A IL84223A0 (en) | 1986-11-07 | 1987-10-20 | Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4847300A (xx) |
| EP (1) | EP0268912A3 (xx) |
| JP (1) | JPS63183524A (xx) |
| KR (1) | KR880005926A (xx) |
| AU (1) | AU601771B2 (xx) |
| CA (1) | CA1307741C (xx) |
| DK (1) | DK546287A (xx) |
| IE (1) | IE872994L (xx) |
| IL (1) | IL84223A0 (xx) |
| NZ (1) | NZ222464A (xx) |
| PH (1) | PH23840A (xx) |
| PT (1) | PT86059B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
| US5854290A (en) * | 1995-09-21 | 1998-12-29 | Amy F. T. Arnsten | Use of guanfacine in the treatment of behavioral disorders |
| WO2006125324A1 (en) * | 2005-05-27 | 2006-11-30 | Queen's University At Kingston | Treatment of protein folding disorders |
| US20090076156A1 (en) * | 2005-07-18 | 2009-03-19 | Masud Husain | Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders |
| FR2893844B1 (fr) * | 2005-11-28 | 2008-02-01 | Centre Nat Rech Scient | Utilisation du guanabenz et de ses derives pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules |
| US20120041068A1 (en) * | 2010-08-11 | 2012-02-16 | Aptapharma, Inc. | Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE893276A (fr) * | 1981-06-01 | 1982-11-24 | Sandoz Sa | Nouvelle application therapeutique d'un derive de l'acetamide |
| CH649918A5 (de) * | 1981-07-09 | 1985-06-28 | Sandoz Ag | Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie. |
-
1986
- 1986-11-07 US US06/928,442 patent/US4847300A/en not_active Expired - Lifetime
-
1987
- 1987-10-14 AU AU79770/87A patent/AU601771B2/en not_active Ceased
- 1987-10-19 DK DK546287A patent/DK546287A/da not_active Application Discontinuation
- 1987-10-20 IL IL84223A patent/IL84223A0/xx unknown
- 1987-10-22 PH PH35973A patent/PH23840A/en unknown
- 1987-10-29 JP JP62271984A patent/JPS63183524A/ja active Pending
- 1987-11-02 PT PT86059A patent/PT86059B/pt not_active IP Right Cessation
- 1987-11-05 NZ NZ222464A patent/NZ222464A/xx unknown
- 1987-11-06 IE IE872994A patent/IE872994L/xx unknown
- 1987-11-06 CA CA000551279A patent/CA1307741C/en not_active Expired - Lifetime
- 1987-11-07 EP EP87116470A patent/EP0268912A3/en not_active Withdrawn
- 1987-11-07 KR KR870012549A patent/KR880005926A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0268912A2 (en) | 1988-06-01 |
| CA1307741C (en) | 1992-09-22 |
| PT86059A (en) | 1987-12-01 |
| AU7977087A (en) | 1988-05-12 |
| EP0268912A3 (en) | 1990-02-28 |
| PT86059B (pt) | 1990-07-31 |
| DK546287A (da) | 1988-05-08 |
| JPS63183524A (ja) | 1988-07-28 |
| PH23840A (en) | 1989-11-23 |
| NZ222464A (en) | 1990-08-28 |
| DK546287D0 (da) | 1987-10-19 |
| US4847300A (en) | 1989-07-11 |
| IE872994L (en) | 1988-05-07 |
| AU601771B2 (en) | 1990-09-20 |
| KR880005926A (ko) | 1988-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2193633B (en) | Psycho-active pharmaceutical compositions containing indolyl derivatives | |
| HUT47500A (en) | Feeding package for liquid matters | |
| DE3379696D1 (en) | Multiplexed-address interface for addressing memories of various sizes | |
| EP0246767A3 (en) | Semiconductor memories | |
| IL71126A0 (en) | Azole compounds,their preparation and pharmaceutical compositions containing them | |
| HK8488A (en) | Antifungal agents,processes for their preparation,and pharmaceutical compositions containing them | |
| NZ212540A (en) | Ganglioside derivatives, and pharmaceutical compositions containing such | |
| HK7091A (en) | Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives | |
| IL72085A (en) | 13alpha-alkylgonanes,processes for their preparation and pharmaceutical compositions containing them | |
| IL70966A0 (en) | Imidazoline derivatives and related compounds,their preparation and pharmaceutical compositions containing them | |
| ZA849499B (en) | Indole derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| IL71203A0 (en) | Azoles,their preparation and pharmaceutical compositions containing them | |
| IL74481A (en) | Pharmaceutical compositions containing quaternary 3,4-dihydroisoquinolinium salts | |
| IL82645A0 (en) | Pharmaceutical compositions containing polypeptides | |
| IL84223A0 (en) | Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement | |
| NZ220747A (en) | Pharmaceutical compositions containing 1,3-oxazolidin-2- one derivatives | |
| IL64880A0 (en) | Imidazoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing them | |
| KR910006110B1 (en) | Memory device using address multiplexing | |
| GR890100177A (en) | Process for preparing pharmaceutical compositions containing sodium cromoclycate | |
| EP0436323A3 (en) | Semiconductor memories | |
| EP0282895A3 (en) | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | |
| IL70992A0 (en) | Hydantoin derivatives,their preparation and pharmaceutical compositions containing them | |
| GB8726517D0 (en) | Substance/composition for pregnancy-induced hypertension | |
| IL76837A0 (en) | Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them | |
| IL84857A0 (en) | Pharmaceutical compositions containing certain pyranoquinoline derivatives |